Sleep & breathing
Positional therapy for position-dependent sleep apnea
Apnea-hypopnea index and daytime sleepiness in position-dependent obstructive sleep apnea.
Grade C: human trials exist, but they are small, mixed or not yet repeated. This is not a finding that it does not work. How to read a grade →
At a glance
Some people have sleep apnea mostly when they lie on their back. A small device worn on the neck buzzes when they roll onto it. In one study it cut breathing pauses a little, but people were not less sleepy in the daytime.
As studied, and the trials
A double-blind Neither the participants nor the people assessing them know who received the real treatment until the trial ends. sham-controlled trial in 120 adults lowered the apnea-hypopnea index by 4.4 events an hour, with no change in Epworth sleepiness (Kelly et al., Thorax, 2026; PMID 40992934). A meta-analysis A study that pools the numbers from several trials into one combined estimate. reported larger falls, but it pooled cohort studies An observational study that follows a group of people over time and compares what happens to them. against baseline, which cannot carry a letter; it is shown on the record as context. One controlled trial: C.
Read the grade that matches your goal. How EBL grades by use →
A letter describes the human evidence, not the product, the manufacturer, or the intervention's worth.
See the full evidence record →Graded on Apnea-hypopnea index in sleep apnea that is worse lying on the back.
Why this letter
Why this gradeGrade C, small or unreplicated trials. The reasoning, and what the grade does not cover.
Grade C on the apnea-hypopnea index in position-dependent sleep apnea: one sham-controlled randomized trial lowered it by 4.4 events an hour without changing daytime sleepiness (Kelly et al., 2026; PMID 40992934).
WHY NOT Bone trial nobody has repeated; the meta-analysis reporting larger falls pooled cohort studies against baseline (PMID 37344178).
WHAT THIS GRADE DOES NOT COVERpillows, backpacks and tennis-ball methods, which the cited trial did not test; sleep apnea that is not position-dependent; and daytime sleepiness, which did not change in the trial.
A grade describes the human evidence for a named use. It is not advice, and it is not a judgment on any individual prescription. How the letters are decided →
Evidence notes: randomized trial
Endpoint The outcome a trial measures to decide whether the treatment worked, such as heart attacks, blood pressure or a symptom score. graded: Apnea-hypopnea index in sleep apnea that is worse lying on the back (surrogate)
Last reviewed: October 2026
The trial that would change this grade.
A positive trial of this shape, supported by further trials, would move this entry to B.
Why the current trials fall short
One sham-controlled trial exists. A second one repeating its result is what B requires.
Why people believe itOne human source; no published case reports of benefit; no reports of harm.
The case for positional therapy is that many people's breathing pauses cluster on their back, so keeping them off it looks like a simple fix.
What supporters point to, and what each source actually shows. None of it is enough to move this letter higher; the trial described above under Evidence wanted is what would.
- Population study, not a trialPooling 18 studies, positional devices lowered the apnea-hypopnea index by about 9 events an hour from baseline, but most comparisons were before and after, without a control. PMID 37344178
A case report describes what happened to one or a few patients. It cannot show the treatment caused the change, and reports of success are published more often than reports of failure.
A PubMed search in October 2026 found no published case report of benefit for this use.
Searched PubMed, October 2026: 8 case report record(s) returned. Single patients with unusual central or complex apnea patterns; none bears on the graded outcome.
Dose, form and timing
Apnea-hypopnea index by body position on a home study, time spent on the back, and the Epworth Sleepiness Scale.
Safety
No safety concerns were reported in the cited trial. Some users report that the vibration disturbs sleep.
Grade history
How this letter has changedLatest: No. 367 · October 2026 · First graded.
Devices that keep sleepers off their back now have a record. One sham-controlled trial in 120 adults lowered breathing pauses by 4.4 an hour without changing daytime sleepiness (Kelly et al., Thorax, 2026; PMID 40992934). Grade C.PMID 40992934
Every change to a letter on this site is dated and published. The full evidence log →
Sources
- Citations
- Every paper cited on this page is matched to its PubMed record on every build.
- Retractions
- None of these papers is retracted or under a journal expression of concern. PubMed is checked again on every build.
- Read against the papers
- October 2026. By a language model (AI-assisted reading), not yet reviewed by a clinician.
- Outside review
- Not yet done. No reviewer outside EBL has checked this record.
What each of these checks can and cannot show: evidence integrity.
Primary evidenceTwo papers, each linked to its PubMed record.
Kelly et al. (Thorax, 2026; PMID 40992934): double-blind sham-controlled multicenter trial, 120 patients, 3 months. ALQarni et al. (Thorax, 2023; PMID 37344178): meta-analysis of 10 randomized and 8 cohort studies against baseline, shown as context.
Evidence Based Longevity, Inc. is owner-operated and edited by Arnold Sandlow, D.C., a California-licensed chiropractor. Evidence Based Longevity publishes in English only · Machine translations are not produced or reviewed by EBL for accuracy
How EBL searched for the trials (1 search)
The search that was run, what it returned, and what was left out and why, so the absence of evidence can be checked as well as its presence.
("positional therapy"[tiab] OR "positional treatment"[tiab] OR "vibrotactile"[tiab]) AND "sleep apnea"[tiab] AND (randomized controlled trial[pt] OR meta-analysis[pt])Disclosure
Educational use only · Not medical advice · EBL grades published human evidence and does not recommend treatment. Stopping a prescription is a decision for your physician.
This page carries a letter. No letter has been bought and none is for sale. Products listed under this modality may be commercial partners, and their purchase links may earn EBL a commission. Those products carry no letter of their own, every relationship is disclosed beside the link, and where a product does not deliver what the trials tested, this page says so regardless of who pays.
How this is enforced
That is not a promise, it is a build condition. Two checks run on every deploy: one refuses to publish if a page says EBL earns a commission on anything that carries a letter, the other refuses if a page names a commercial relationship that is not declared in the register. If either fails, this page does not go live. You can read how the checks work, and what they do not cover, on the evidence integrity page.
© Evidence Based Longevity, Inc.. All rights reserved
These statements have not been evaluated by the Food and Drug Administration. Any grade on this page describes the strength of published human trial evidence in the populations studied. It is not a recommendation for any individual and is not medical advice. Starting, stopping or changing any supplement or medication is a decision for your physician.
Grades move when new trials publish. A free monthly email lists every grade EBL moved, with the reason and the trial behind it: the sign-up is on the Evidence Log →